An Open-Label Study to Assess the Steady-State Pharmacokinetics, Safety and Tolerability of Seroquel XR (Quetiapine Fumarate) Extended-ReleaseTablets and Seroquel IR (Quetiapine Fumarate) Immediate ReleaseTablets in Children and Adolescents with selected Psychotic and Mood Disorders

*Please Note* The Study information you are attempting to view is not available on ClinicalTrials.gov as the Study predates the Food and Drug Administration Amendments Act (FDAAA), Section 801 requirements. More information regarding this study may be available by contacting [email protected].

*Please Note* The Study information you are attempting to view is not available on ClinicalTrials.gov as the Study predates the Food and Drug Administration Amendments Act (FDAAA), Section 801 requirements. More information regarding this study may be available by contacting [email protected].